Roche Holding AG said on Wednesday its cancer drug, Venclexta, received accelerated approval from the U.S. Food and Drug Administration as part of a combination treatment for newly diagnosed patients with a form of leukemia.


00


Reuters

Latest News

FOX: Adam Levine addresses controversial 'Voice' elimination after fans slam judge's plea

FOX: Gutfeld on the no-host Oscars

FOX: Trump trades shutdown threats with Pelosi, Schumer

FOX: Meng Wanzhou, Chinese telecom exec facing possible extradition to US, granted bail by Canadian judge

FOX: Judge orders Stormy Daniels to pay Trump almost $300,000

CBS: How a rural North Carolina county became the center of an election scandal

CBS: "Yellow Vest" movement leaders say protests will continue despite Macron's concessions

CBS: Analysis: Why Democrats are wary of impeachment

CNBC: Energy expert says oil rally here to stay and these are names to buy on the bounce

CNBC: One trader just made a $3.5 million bet against Coca-Cola and here's why

CNBC: Final Trades: TGT, HD & more

CNBC: Cramer: Pick individual stocks with long-term growth stories in this 'treacherous' market

BBC: Grenfell Tower fire: Hearings 'may slip back to 2020'

CTV News: Court wrong to say charter doesn't apply to brain-dead woman, family argues

CTV News: Sheldon Kennedy elects to have his name removed from Child Advocacy Centre

ABC: A Canadian judge has granted bail to a Chinese executive facing possible extradition to the U.S.

CTV News: Cenovus, Athabasca unveil growth-constrained 2019 capital budget plans

Reuters: Canadian court grants bail to CFO of China's Huawei

Reuters: DoubleLine's Gundlach says S&P 500 likely to go below its February 2018 lows

Reuters: China's Tencent Music raises nearly $1.1 billion in U.S. IPO

Haaretz: In Poland, pierogi and herring have their day in the sun

WashingtonPost: House GOP leader calls on Herring to step down as Va. attorney general if he runs for governor

WashingtonPost: The major climate-change solution hiding in plain sight: Nature

11 Related Articles, between 2018-11-19 and 2018-11-21